97
Viking Therapeutics‘ year-to-date stock performance.
Altria Group‘s year-to-date stock performance.
Altria Group: “I won’t recommend it personally, but I can’t fight it.”
Zoom’s year-to-date stock performance.
Zoom: “I think Zoom is a good company…I just lack a catalyst about why to recommend it, so therefore I’m going to take a pass.”
ProFrac’s year-to-date stock performance.
ProFrac: “I’m really anti the oils right now, I think they’re all going lower. I do not want to to touch them.”
